All the comments about randomised trials are fair. Yes, you can (and probably should) do them in this population. Although to be fair the role for much radiotherapy is a bit light for evidence. Yes they will need to be done for FDA. Yes clinicians will want to see some done. Journals want randomised trials to publish.
But I have asked the CEO directly - twice - whether or not a randomised trial of any kind was specified, requested or expected for CE approval process.
The answer both times was an emphatic no.
Ann: Half Yearly Report and Accounts, page-57
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.001(9.09%) |
Mkt cap ! $45.40M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $18.92K | 1.705M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 13619110 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 5063491 | 9 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |